PLIVA FDA Approval ANDA 089060

ANDA 089060

PLIVA

FDA Drug Application

Application #089060

Application Sponsors

ANDA 089060PLIVA

Marketing Status

Prescription001

Application Products

001TABLET;ORAL2MG0BENZTROPINE MESYLATEBENZTROPINE MESYLATE

FDA Submissions

ORIG1AP1988-08-10
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1992-09-24
BIOEQUIV; BioequivalenceSUPPL3AP1992-09-24
LABELING; LabelingSUPPL4AP1998-03-09
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1994-05-11
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1997-08-13
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1997-08-13
LABELING; LabelingSUPPL8AP1998-10-27
MANUF (CMC); Manufacturing (CMC)SUPPL9AP2000-07-07
MANUF (CMC); Manufacturing (CMC)SUPPL10AP2001-05-29
LABELING; LabelingSUPPL11AP2001-12-10

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL9Null0
SUPPL10Null0

TE Codes

001PrescriptionAA

CDER Filings

PLIVA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 89060
            [companyName] => PLIVA
            [docInserts] => ["",""]
            [products] => [{"drugName":"BENZTROPINE MESYLATE","activeIngredients":"BENZTROPINE MESYLATE","strength":"2MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"BENZTROPINE MESYLATE","submission":"BENZTROPINE MESYLATE","actionType":"2MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.